Semi-solid extruded tablets for personalized pediatric use: Development, Quality control and In-Vitro Assessment of Enteral Tube Administration
Authors:
Open Access
- 10 May 2025
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 211, 107122
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Personalized Medicine Through Semisolid-Extrusion Based 3D Printing: Dual-Drug Loaded Gummies for Enhanced Patient CompliancePharmaceutical Research, 2025
- 3D printed dispersible efavirenz tablets: A strategy for nasogastric administration in childrenInternational Journal of Pharmaceutics, 2024
- Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challengesJournal of Controlled Release, 2021
- Considerations for the Use of Polysorbates in BiopharmaceuticalsPharmaceutical Research, 2018
- Bioactively filled gelatin gels; challenges and opportunitiesFood Hydrocolloids, 2018
- Channelled tablets: An innovative approach to accelerating drug release from 3D printed tabletsJournal of Controlled Release, 2018
- Effect of geometry on drug release from 3D printed tabletsInternational Journal of Pharmaceutics, 2015
- Quantitative analysis of drug losses administered via nasogastric tube – In vitro studyInternational Journal of Pharmaceutics, 2015
- The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugsInternational Journal of Pharmaceutics, 2006
- Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenololJournal of Pharmaceutical Sciences, 2004